The Parkinson’s Shift: We Are Finally Moving Beyond Symptom Chasing
Biomarkers, continuous levodopa delivery, GLP-1 drugs, and cell therapy are changing the Parkinson’s conversation. But patients need precision, not hype.
What health care proxies, durable powers of attorney, living wills, and wills actually do, and why people with chronic illness cannot afford to put them off.
